OPKO Health (OPK) Announces Submission of NDA to U.S. FDA for Oral Rayaldee
Tweet Send to a Friend
OPKO Health (NYSE: OPK) announced that it has submitted a New Drug Application (NDA) for oral Rayaldee to the U.S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
